$BIVV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Bioverativ Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Bioverativ Inc.. Get notifications about new insider transactions in Bioverativ Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 08 2018 | BIVV | Bioverativ Inc. | Protopapas Anna | Director | Option Exercise | D | 52.08 | 23,006 | 1,198,152 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Protopapas Anna | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Protopapas Anna | Director | Sell | D | 0.00 | 1,056 | 0 | 0 | 1.1 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | D | 44.51 | 26,818 | 1,193,669 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | D | 44.51 | 2,980 | 132,640 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | D | 0.00 | 6,364 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Sell | D | 0.00 | 6,693 | 0 | 0 | 6.7 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Option Exercise | D | 44.51 | 26,818 | 1,193,669 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Sell | D | 0.00 | 3,056 | 0 | 0 | 3.1 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Gift | G | 0.00 | 2,000 | 0 | 3,056 | 5.1 K to 3.1 K (-39.56 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | D | 56.34 | 33,759 | 1,901,982 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | D | 56.34 | 34,556 | 1,946,885 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | D | 0.00 | 40,909 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | D | 0.00 | 11,271 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Sell | D | 0.00 | 839 | 0 | 0 | 839 to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 44.51 | 56,615 | 2,519,934 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 44.51 | 113,230 | 5,039,867 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 0.00 | 42,727 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | D | 0.00 | 14,230 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Sell | D | 0.00 | 5,951 | 0 | 0 | 6 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | D | 55.04 | 21,729 | 1,195,964 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 44.51 | 11,062 | 492,370 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 52.08 | 7,030 | 366,122 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 0.00 | 7,273 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | D | 0.00 | 2,780 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Sell | D | 0.00 | 2,791 | 0 | 0 | 2.8 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | D | 44.51 | 29,797 | 1,326,264 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | D | 44.51 | 59,595 | 2,652,573 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | D | 44.51 | 29,797 | 1,326,264 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | D | 0.00 | 31,818 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | D | 0.00 | 7,489 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Sell | D | 0.00 | 30,600 | 0 | 0 | 30.6 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | D | 44.51 | 26,818 | 1,193,669 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | D | 0.00 | 5,455 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 1,165,000 | 0 | 0 | 1.2 M to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Sell | D | 0.00 | 5,001 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 44.51 | 193,683 | 8,620,830 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 44.51 | 387,366 | 17,241,661 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 7.82 | 48,230 | 377,159 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 0.00 | 48,678 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | D | 0.00 | 136,364 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Sell | D | 0.00 | 185,094 | 0 | 0 | 185.1 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 44.51 | 56,615 | 2,519,934 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 44.51 | 113,230 | 5,039,867 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 0.00 | 42,727 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | D | 0.00 | 14,230 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Sell | D | 0.00 | 5,758 | 0 | 0 | 5.8 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | D | 44.51 | 29,797 | 1,326,264 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | D | 44.51 | 59,595 | 2,652,573 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | D | 44.51 | 14,899 | 663,154 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | D | 0.00 | 31,818 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | D | 0.00 | 7,489 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Sell | D | 0.00 | 20,396 | 0 | 0 | 20.4 K to 0 (-100.00 %) |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | D | 44.51 | 59,595 | 2,652,573 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | D | 44.51 | 29,797 | 1,326,264 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | D | 44.51 | 14,899 | 663,154 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | D | 0.00 | 31,818 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | D | 0.00 | 7,489 | 0 | 0 | |
| Mar 08 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Sell | D | 0.00 | 22,952 | 0 | 0 | 23 K to 0 (-100.00 %) |
| Mar 05 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 104.73 | 105 | 10,997 | 2,791 | 2.9 K to 2.8 K (-3.63 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 104.30 | 168 | 17,522 | 2,896 | 3.1 K to 2.9 K (-5.48 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 104.74 | 5,794 | 606,864 | 185,094 | 190.9 K to 185.1 K (-3.04 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 104.30 | 13,973 | 1,457,384 | 190,888 | 204.9 K to 190.9 K (-6.82 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 104.74 | 389 | 40,744 | 20,016 | 20.4 K to 20 K (-1.91 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 104.30 | 1,235 | 128,811 | 20,405 | 21.6 K to 20.4 K (-5.71 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Payment of Exercise | F | 104.74 | 917 | 96,047 | 30,411 | 31.3 K to 30.4 K (-2.93 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Payment of Exercise | F | 104.30 | 2,011 | 209,747 | 31,328 | 33.3 K to 31.3 K (-6.03 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Payment of Exercise | F | 104.74 | 924 | 96,780 | 22,952 | 23.9 K to 23 K (-3.87 %) |
| Feb 26 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Payment of Exercise | F | 104.30 | 1,419 | 148,002 | 23,876 | 25.3 K to 23.9 K (-5.61 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | M | 0.00 | 7,114 | 0 | 14,230 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Payment of Exercise | F | 103.52 | 2,118 | 219,255 | 5,496 | 7.6 K to 5.5 K (-27.82 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Buy | M | 0.00 | 7,114 | 0 | 7,614 | 500 to 7.6 K (+1,422.80 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Option Exercise | M | 0.00 | 1,390 | 0 | 2,780 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 103.52 | 454 | 46,998 | 3,064 | 3.5 K to 3.1 K (-12.91 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Buy | M | 0.00 | 1,390 | 0 | 3,518 | 2.1 K to 3.5 K (+65.32 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | M | 0.00 | 7,114 | 0 | 14,230 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Payment of Exercise | F | 103.52 | 2,126 | 220,084 | 5,303 | 7.4 K to 5.3 K (-28.62 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Buy | M | 0.00 | 7,114 | 0 | 7,429 | 315 to 7.4 K (+2,258.41 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | M | 0.00 | 3,744 | 0 | 7,489 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Payment of Exercise | F | 103.52 | 1,137 | 117,702 | 25,295 | 26.4 K to 25.3 K (-4.30 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Buy | M | 0.00 | 3,744 | 0 | 26,432 | 22.7 K to 26.4 K (+16.50 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | M | 0.00 | 24,339 | 0 | 48,678 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 103.52 | 10,819 | 1,119,983 | 204,861 | 215.7 K to 204.9 K (-5.02 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Buy | M | 0.00 | 24,339 | 0 | 215,680 | 191.3 K to 215.7 K (+12.72 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | M | 0.00 | 3,744 | 0 | 7,489 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 103.52 | 1,141 | 118,116 | 21,640 | 22.8 K to 21.6 K (-5.01 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Buy | M | 0.00 | 3,744 | 0 | 22,781 | 19 K to 22.8 K (+19.67 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | M | 0.00 | 3,744 | 0 | 7,489 | |
| Feb 15 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Payment of Exercise | F | 103.52 | 1,136 | 117,599 | 33,339 | 34.5 K to 33.3 K (-3.30 %) |
| Feb 15 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Buy | M | 0.00 | 3,744 | 0 | 34,475 | 30.7 K to 34.5 K (+12.18 %) |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | M | 9.53 | 18,381 | 175,171 | 0 | |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 103.05 | 7,672 | 790,600 | 191,341 | 199 K to 191.3 K (-3.86 %) |
| Feb 13 2018 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Buy | M | 9.53 | 18,381 | 175,171 | 199,013 | 180.6 K to 199 K (+10.18 %) |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | A | 0.00 | 40,909 | 0 | 40,909 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Greene John | EVP, CFO and Treasu ... | Option Exercise | A | 0.00 | 42,727 | 0 | 42,727 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Protopapas Anna | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Option Exercise | A | 0.00 | 31,818 | 0 | 31,818 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Option Exercise | A | 0.00 | 6,364 | 0 | 6,364 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Vivaldi Coelho Rogerio | EVP, Chief Global T ... | Option Exercise | A | 0.00 | 42,727 | 0 | 42,727 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | Brudnick Richard | EVP, Business Devel ... | Option Exercise | A | 0.00 | 31,818 | 0 | 31,818 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Option Exercise | A | 0.00 | 31,818 | 0 | 31,818 | |
| Feb 02 2018 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Option Exercise | A | 0.00 | 5,455 | 0 | 5,455 | |
| Nov 03 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 53.65 | 318 | 17,061 | 18,928 | 19.2 K to 18.9 K (-1.65 %) |
| Nov 03 2017 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Payment of Exercise | F | 53.65 | 636 | 34,121 | 30,731 | 31.4 K to 30.7 K (-2.03 %) |
| Aug 31 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Grant | A | 56.69 | 932 | 52,835 | 1,165,000 | 1.2 M to 1.2 M (+0.08 %) |
| Aug 10 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Buy | P | 59.19 | 1,000 | 59,190 | 6,693 | 5.7 K to 6.7 K (+17.57 %) |
| Aug 08 2017 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Buy | P | 59.70 | 2,000 | 119,400 | 5,056 | 3.1 K to 5.1 K (+65.45 %) |
| Jun 29 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Sell | S | 60.47 | 818 | 49,464 | 2,128 | 2.9 K to 2.1 K (-27.77 %) |
| Jun 01 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 55.93 | 90,000 | 5,033,475 | 1,165,000 | 1.1 M to 1.2 M (+8.37 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 57.21 | 450,000 | 25,745,130 | 1,075,000 | 625 K to 1.1 M (+72.00 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 54.98 | 130,000 | 7,147,907 | 625,000 | 495 K to 625 K (+26.26 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Buy | P | 54.16 | 340,000 | 18,414,400 | 495,000 | 155 K to 495 K (+219.35 %) |
| May 26 2017 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Buy | P | 57.76 | 2,000 | 115,520 | 3,056 | 1.1 K to 3.1 K (+189.39 %) |
| May 24 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Buy | P | 53.79 | 700 | 37,656 | 5,693 | 5 K to 5.7 K (+14.02 %) |
| May 24 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Buy | P | 53.90 | 1,300 | 70,068 | 4,993 | 3.7 K to 5 K (+35.20 %) |
| May 15 2017 | BIVV | Bioverativ Inc. | Germano Geno J | Director | Option Exercise | A | 55.04 | 21,729 | 1,195,964 | 21,729 | |
| May 03 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 57.48 | 99 | 5,691 | 2,946 | 3 K to 2.9 K (-3.25 %) |
| Apr 17 2017 | BIVV | Bioverativ Inc. | DENNER ALEXANDER J | Director | Grant | A | 56.83 | 1,056 | 60,012 | 5,001 | 3.9 K to 5 K (+26.77 %) |
| Apr 17 2017 | BIVV | Bioverativ Inc. | Protopapas Anna | Director | Grant | A | 56.83 | 1,056 | 60,012 | 1,056 | 0 to 1.1 K |
| Apr 17 2017 | BIVV | Bioverativ Inc. | PAGLIA LOUIS J | Director | Grant | A | 56.83 | 1,056 | 60,012 | 1,056 | 0 to 1.1 K |
| Apr 17 2017 | BIVV | Bioverativ Inc. | Posner Brian S | Director | Grant | A | 56.83 | 1,056 | 60,012 | 3,693 | 2.6 K to 3.7 K (+40.05 %) |
| Apr 11 2017 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | A | 0.00 | 11,271 | 0 | 11,271 | |
| Apr 11 2017 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | A | 56.34 | 33,759 | 1,901,982 | 33,759 | |
| Apr 11 2017 | BIVV | Bioverativ Inc. | Harris Timothy J.R. | EVP, R & D | Option Exercise | A | 56.34 | 34,556 | 1,946,885 | 34,556 | |
| Apr 03 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 54.46 | 8,416 | 458,335 | 180,632 | 189 K to 180.6 K (-4.45 %) |
| Mar 03 2017 | BIVV | Bioverativ Inc. | Duvall Diantha | Chief Accounting Of ... | Payment of Exercise | F | 52.81 | 113 | 5,968 | 3,045 | 3.2 K to 3 K (-3.58 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 43.42 | 790 | 34,302 | 19,049 | 19.8 K to 19 K (-3.98 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 47.76 | 592 | 28,274 | 19,839 | 20.4 K to 19.8 K (-2.90 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 49.56 | 182 | 9,020 | 20,431 | 20.6 K to 20.4 K (-0.88 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 43.42 | 301 | 13,069 | 20,613 | 20.9 K to 20.6 K (-1.44 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 47.76 | 768 | 36,680 | 20,914 | 21.7 K to 20.9 K (-3.54 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 49.56 | 235 | 11,647 | 21,682 | 21.9 K to 21.7 K (-1.07 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Payment of Exercise | F | 43.42 | 650 | 28,223 | 21,917 | 22.6 K to 21.9 K (-2.88 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Celona Lucia | EVP, HR & Corp Comm ... | Grant | A | 0.00 | 22,567 | 0 | 22,567 | 0 to 22.6 K |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 9.53 | 18,381 | 175,171 | 18,381 | |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Option Exercise | A | 7.82 | 48,230 | 377,159 | 48,230 | |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 43.42 | 6,726 | 292,043 | 189,048 | 195.8 K to 189 K (-3.44 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 47.76 | 6,436 | 307,383 | 195,774 | 202.2 K to 195.8 K (-3.18 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 49.56 | 2,641 | 130,888 | 202,210 | 204.9 K to 202.2 K (-1.29 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 43.42 | 6,986 | 303,332 | 204,851 | 211.8 K to 204.9 K (-3.30 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 47.76 | 8,355 | 399,035 | 211,837 | 220.2 K to 211.8 K (-3.79 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 49.56 | 3,383 | 167,661 | 220,192 | 223.6 K to 220.2 K (-1.51 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Payment of Exercise | F | 43.42 | 3,404 | 147,802 | 223,575 | 227 K to 223.6 K (-1.50 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | Cox John | Chief Executive Off ... | Grant | A | 0.00 | 211,679 | 0 | 226,979 | 15.3 K to 227 K (+1,383.52 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Payment of Exercise | F | 43.42 | 718 | 31,176 | 30,818 | 31.5 K to 30.8 K (-2.28 %) |
| Mar 02 2017 | BIVV | Bioverativ Inc. | DiFabio Andrea | EVP, Chief Legal Of ... | Payment of Exercise | F | 47.76 | 918 | 43,844 | 31,536 | 32.5 K to 31.5 K (-2.83 %) |